Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

Share Price is delayed by 15 minutes
Get Live Data
210.60    3.00 (1.45%)
Bid:
209.80
Ask:
210.20
Spread: 0.40 (0.191%)
Market Cap: £916.68m
KIE Live PriceLast checked at - London Stock Exchange

Intraday Kier Share Chart

Trading Update

22 Jan 2019 07:00

RNS Number : 6990N
Kier Group PLC
22 January 2019
 

22 January 2019

 

KIER GROUP PLC - TRADING UPDATE

 

Kier Group plc ("the Group"), a leading infrastructure services, buildings and developments & housing group, announces its trading update covering the period since its previous trading update of 16 November 2018. The Group will announce its half-year results on 21 March 2019.

 

Highlights include:

· On track to meet its FY19 expectations;

· Average month-end net debt of c.£370m (H2 FY18: £410m), reflecting the impact of the recent rights issue; and

· The Future Proofing Kier programme (the "FPK programme") is progressing well.

 

TradingThe Board is confident that the Group will meet its FY19 expectations, with the full-year results being weighted towards the second half of the financial year, as usual.

 

During the period, the Infrastructure Services and Buildings businesses won a number of new contract awards and now have 100% visibility of the forecast revenue for FY19 and an order book of more than £10bn.

 

Examples of recent key awarded contracts include:

· the renewal of a three-year c.£70m utility services contract in the south west of England;

· over £500m of regional building projects secured during November and December, including a major office development for Argent at King's Cross in London, a new research facility for the Pirbright Institute in Surrey, a flagship development for the Royal College of Art and a new hospital for Frimley Health NHS Foundation Trust; and

· being appointed to three lots on the North West Construction Hub three-year £1.5bn framework.

 

In the Developments & Housing businesses, we have experienced a stable housing market, evidenced by a current sales rate of 0.8 units per sales outlet per week (2018: 0.7). In property developments, we have sold all schemes which were forecast to be sold in the period, which highlights the strength of our regional development activities.

 

Future Proofing Kier programme

As previously reported, the costs of implementing the FPK programme in the first half of the financial year have exceeded the savings by £10m. The full-year FY19 position is still expected to be earnings and cashflow neutral and the programme is progressing well.

 

Balance Sheet

The Group's balance sheet at 31 December 2018 has been strengthened following the receipt of the £250m net cash proceeds of the recent rights issue and the Group remains on track to report a net cash position at the year-end (30 June 2019). As at 31 December 2018, the Group's net debt was c.£130m (31 December 2017: £239m), reflecting the rights issue proceeds and the acceleration of supply chain payments, as expected. The average month-end net debt for the six months ended 31 December 2018 was c.£370m, as compared with £410m for the six months ended 30 June 2018.

 

- ENDS -

 

For further information, please contact: 

Louise Turner-Smith, Kier investor relations

+44 (0)7976 790012

Kier press office

+44 (0)1767 355903

Nick Hasell, FTI Consulting

+44 (0)203 727 1340

 

 

Cautionary statement

This announcement does not constitute an offer of securities by Kier Group plc (the "Company"). Nothing in this announcement is intended to be, or intended to be construed as, a profit forecast or a guide as to the performance, financial or otherwise, of the Company or any of its subsidiaries (together, the "Group") whether in the current or any future financial year. This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2018 for a further discussion of the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPGUGGGUPBPGG
Date   Source Headline
1st Nov 202210:07 amRNSTotal Voting Rights
25th Oct 20223:35 pmRNSHolding(s) in Company
24th Oct 20222:28 pmRNSDirector/PDMR Shareholding
19th Oct 20224:17 pmRNSDirector/PDMR Shareholding
12th Oct 20223:59 pmRNSHolding(s) in Company
7th Oct 202211:51 amRNSAnnual Financial Report
3rd Oct 202210:23 amRNSTotal Voting Rights
21st Sep 20223:42 pmRNSDirector/PDMR Shareholding
15th Sep 20227:00 amRNSResults for the year ended 30 June 2022
2nd Sep 202210:08 amRNSHolding(s) in Company
1st Sep 202210:21 amRNSTotal Voting Rights
22nd Aug 202210:11 amRNSDirector/PDMR Shareholding
1st Aug 202210:00 amRNSTotal Voting Rights
29th Jul 20224:05 pmRNSHolding(s) in Company
20th Jul 202212:00 pmRNSDirector/PDMR Shareholding
19th Jul 20227:00 amRNSTrading Update
6th Jul 20227:00 amRNSBoard Appointment
1st Jul 202210:16 amRNSTotal Voting Rights
1st Jul 202210:14 amRNSBlock listing Interim Review
28th Jun 20229:41 amRNSHolding(s) in Company
22nd Jun 20224:29 pmRNSHolding(s) in Company
21st Jun 202211:44 amRNSDirector/PDMR Shareholding
1st Jun 202210:36 amRNSTotal Voting Rights
24th May 20227:00 amRNSTrading Update and Capital Markets Event
20th May 20222:36 pmRNSDirector/PDMR Shareholding
3rd May 202210:30 amRNSTotal Voting Rights
29th Apr 20221:00 pmRNSDirector Declaration
19th Apr 20224:32 pmRNSDirector/PDMR Shareholding
1st Apr 202212:28 pmRNSTotal Voting Rights
21st Mar 20222:05 pmRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSResults for the six months ended 31 December 2021
1st Mar 202212:07 pmRNSTotal Voting Rights
21st Feb 20223:08 pmRNSDirector/PDMR Shareholding
2nd Feb 20223:05 pmRNSHolding(s) in Company
1st Feb 202212:07 pmRNSTotal Voting Rights
20th Jan 202212:18 pmRNSDirector/PDMR Shareholding
20th Jan 20227:00 amRNSTrading Update
4th Jan 202212:05 pmRNSTotal Voting Rights
4th Jan 202212:00 pmRNSBlock listing Interim Review
20th Dec 20214:10 pmRNSDirector/PDMR Shareholding
1st Dec 20212:37 pmRNSTotal Voting Rights
22nd Nov 20213:14 pmRNSDirector/PDMR Shareholding
19th Nov 20212:32 pmRNSResult of AGM
15th Nov 20211:13 pmRNSHolding(s) in Company
1st Nov 20213:17 pmRNSDirector/PDMR Shareholding
1st Nov 20219:38 amRNSTotal Voting Rights
29th Oct 202112:59 pmRNSDirector/PDMR Shareholding
26th Oct 20211:00 pmRNSDirector/PDMR Shareholding
19th Oct 20213:47 pmRNSDirector/PDMR Shareholding
19th Oct 202110:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.